Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.0B | 5.6B | 5.6B | 4.6B |
Cost of revenue | 4.7B | 5.3B | 5.3B | 4.5B |
Gross profit | 298M | 242M | 316M | 191M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 218M | — | — |
Operating income | 144M | -122M | 190M | 43M |
Non operating interest income | ||||
Income | 6M | 9M | 12M | 11M |
Expense | 35M | 43M | 39M | 39M |
Other income expense | — | — | — | — |
Pretax income | -57M | -160M | 26M | -169M |
Tax provision | -17M | -25M | 4M | -24M |
Net income | -40M | -135M | 23M | -144M |
Basic EPS | — | -0.2 | 0.0 | -0.2 |
Diluted EPS | — | -0.2 | 0.0 | -0.2 |
Basic average shares | — | 750M | 766.7M | 768.2M |
Diluted average shares | — | 750M | 766.7M | 768.2M |
EBITDA | -22M | -117M | 65M | -130M |
Net income from continuing op. | -57M | -160M | 26M | -169M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |